The second component of the
economic argument assesses whether the intervention
represents good value for money – the cost–benefit
criterion. Several so-called cost–benefit assessments
exist in areas relevant to the social determinants of
health. While this evidence may be known to the policymakers
from relevant sectors, it may be less known to
the public health person trying to advocate investment
in the social determinants of health.